CSL Limited Company Description
CSL Limited engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.
The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment manufactures, markets, and distributes plasma products, gene therapies, and recombinants.
This segment also offers therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas.
The CSL Seqirus segment manufactures, markets, and distributes influenza related products and pandemic services to governments.
The CSL Vifor segment manufactures, markets, and distributes products in the therapeutic areas of iron deficiency and nephrology.
It also licenses CSL intellectual property. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia.

Country | Australia |
Founded | 1916 |
Industry | Biotechnology |
Sector | Healthcare |
Employees | 29,904 |
CEO | Paul McKenzie |
Contact Details
Address: 655 Elizabeth Street Melbourne, 3000 Australia | |
Phone | 61 3 9389 1911 |
Website | csl.com |
Stock Details
Ticker Symbol | CMXHF |
Exchange | OTCMKTS |
Fiscal Year | July - June |
Reporting Currency | USD |
ISIN Number | AU000000CSL8 |
SIC Code | 2836 |
Key Executives
Name | Position |
---|---|
Dr. Paul F. McKenzie Ph.D. | MD, Chief Executive Officer and Executive Director |
Joy Carolyn Linton B.Com., BComm, GAICD, Grad Dip AFI | Chief Financial Officer |
Andy Schmeltz | Executive Vice President of CSL Behring |
Dr. Mary Oates Ph.D. | Chief Operating Officer |
Chris Cooper | Head of Investor Relations |
Gregory Boss B.S., BS(Hons), J.D. | Executive Vice President of Legal and General Counsel |
Roanne Parry | Chief Human Resources Officer |
Dr. William Mezzanotte M.D., M.P.H. | Chief Medical Officer, Executive Vice President and Head of Research and Development |
Mark Hill B.A., M.B.A. | Chief Digital Information Officer and Executive Vice President |
Deirdre BeVard | Senior Vice President of Research and Development Strategic Operations |